Pharmacokinetics and pharmacodynamics of inhaled GLP-1 (MKC253): proof-of-concept studies in healthy normal volunteers and in patients with type 2 diabetes.

Marino, M T et al.·Clinical pharmacology and therapeutics·2010·
RPEP-016582010RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Pharmacokinetics and pharmacodynamics of inhaled GLP-1 (MKC253): proof-of-concept studies in healthy normal volunteers and in patients with type 2 diabetes.
Published In:
Clinical pharmacology and therapeutics, 88(2), 243-50 (2010)
Database ID:
RPEP-01658

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-01658·https://rethinkpeptides.com/research/RPEP-01658

APA

Marino, M T; Costello, D; Baughman, R; Boss, A; Cassidy, J; Damico, C; van Marle, S; van Vliet, A; Richardson, P C. (2010). Pharmacokinetics and pharmacodynamics of inhaled GLP-1 (MKC253): proof-of-concept studies in healthy normal volunteers and in patients with type 2 diabetes.. Clinical pharmacology and therapeutics, 88(2), 243-50. https://doi.org/10.1038/clpt.2010.85

MLA

Marino, M T, et al. "Pharmacokinetics and pharmacodynamics of inhaled GLP-1 (MKC253): proof-of-concept studies in healthy normal volunteers and in patients with type 2 diabetes.." Clinical pharmacology and therapeutics, 2010. https://doi.org/10.1038/clpt.2010.85

RethinkPeptides

RethinkPeptides Research Database. "Pharmacokinetics and pharmacodynamics of inhaled GLP-1 (MKC2..." RPEP-01658. Retrieved from https://rethinkpeptides.com/research/marino-2010-pharmacokinetics-and-pharmacodynamics-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.